Current status of superparamagnetic iron oxide contrast agents for liver magnetic resonance imaging

World Journal of Gastroenterology

Volumn 21, Issue 47, 2015, Pages 13400-13402

  Wang, Yi Xiang J ^a  

^a Prince of Wales Hospital   (Hong Kong)

Author keywords

Eovist; Gd EOB DTPA; Hepatocellular carcinoma; Liver; Magnetic resonance imaging; Primovist; Resovist; Superparamagnetic iron oxide

Indexed keywords

FERUCARBOTRAN; FERUMOXYTOL; GADOXETIC ACID; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; CONTRAST MEDIUM; DEXTRAN; GADOLINIUM PENTETATE; IRON; MAGNETITE NANOPARTICLE; OXIDE;

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CONTRAST ENHANCEMENT; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; IRON DEFICIENCY; LIVER CELL CARCINOMA; LIVER INJURY; MAGNETIC RESONANCE ANGIOGRAPHY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; SENSITIVITY AND SPECIFICITY;

CONTRAST MEDIA; DEXTRANS; GADOLINIUM DTPA; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; OXIDES;

EID: 84951857216     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i47.13400     Document Type: Article

References (13)

1. Li YW, Chen ZG, Wang JC, Zhang ZM. Superparamagnetic iron oxide-enhanced magnetic resonance imaging for focal hepatic lesions: systematic review and meta-analysis. World J Gastroenterol 2015; 21: 4334-4344 [PMID: 25892885 DOI: 10.3748/wjg.v21. i14.4334]
2. Corot C, Robert P, Idée JM, Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 2006; 58: 1471-1504 [PMID: 17116343 DOI: 10.1016/ j.addr.2006.09.013]
3. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001; 11: 2319-2331 [PMID: 11702180 DOI: 10.1007/s003300100908]
4. Wang YX. Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application. Quant Imaging Med Surg 2011; 1: 35-40 [PMID: 23256052]
5. Klein C, Nagel E, Schnackenburg B, Bornstedt A, Schalla S, Hoffmann V, Lehning A, Fleck E. The intravascular contrast agent Clariscan (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease. MAGMA 2000; 11: 65-67 [PMID: 11186991 DOI: 10.1007/BF02678498]
6. Wagner M, Wagner S, Schnorr J, Schellenberger E, Kivelitz D, Krug L, Dewey M, Laule M, Hamm B, Taupitz M. Coronary MR angiography using citrate-coated very small superparamagnetic iron oxide particles as blood-pool contrast agent: initial experience in humans. J Magn Reson Imaging 2011; 34: 816-823 [PMID: 21769977 DOI: 10.1002/jmri.22683]
7. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003; 348: 2491-2499 [PMID: 12815134 DOI: 10.1056/NEJMoa022749]
8. European Medicines Agency. International Nonproprietary Name (INN): superparamagnetic iron oxide nanoparticles stabilised with dextran and sodium citrate. 2008. Available from: URL: http://www.ema.europa.eu/docs/en-GB/document-library/Application-withdrawal-assessment-report/2010/01/WC500067463.pdf
9. Tanaka M, Nakashima O, Wada Y, Kage M, Kojiro M. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology 1996; 24: 807-812 [PMID: 8855180 DOI: 10.1053/jhep.1996.v24. pm0008855180]
10. Kim YK, Kim CS, Kwak HS, Lee JM. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging. J Magn Reson Imaging 2004; 20: 826-837 [PMID: 15503325 DOI: 10.1002/jmri.20188]
11. Maurea S, Mainenti PP, Tambasco A, Imbriaco M, Mollica C, Laccetti E, Camera L, Liuzzi R, Salvatore M. Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media. Quant Imaging Med Surg 2014; 4: 181-189 [PMID: 24914419]
12. Bashir MR, Bhatti L, Marin D, Nelson RC. Emerging applications for ferumoxytol as a contrast agent in MRI. J Magn Reson Imaging 2015; 41: 884-898 [PMID: 24974785 DOI: 10.1002/jmri.24691]
13. Lee JM, Park JW, Choi BI. 2014 KLCSG-NCC Korea Practice Guidelines for the management of hepatocellular carcinoma: HCC diagnostic algorithm. Dig Dis 2014; 32: 764-777 [PMID: 25376295 DOI: 10.1159/000368020]